ROSUVASTATIN-RL rosuvastatin (as calcium) 5 mg film-coated tablets blister pack

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

rosuvastatin calcium, Quantity: 5.2 mg

から入手可能:

Dr Reddys Laboratories Australia Pty Ltd

INN（国際名）:

Rosuvastatin calcium

医薬品形態:

Tablet, film coated

構図:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; meglumine; magnesium stearate; titanium dioxide; indigo carmine aluminium lake; hypromellose; triacetin; allura red AC aluminium lake; quinoline yellow aluminium lake

投与経路:

Oral

パッケージ内のユニット:

7 tablets, 30 tablets

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.,- Prevention of Cardiovascular Events,Rosuvastatin is indicated for prevention of major cardiovascular events in men greater than or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking, or a family history of premature coronary heart disease). Rosuvastatin is indicated to:,? Reduce the risk of nonfatal myocardial infarction,? Reduce the risk of nonfatal stroke,? Reduce the risk of coronary artery revascularisation procedures.,- In patients with hypercholesterolaemia,Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia).,Prior to initiating therapy with rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic s

製品概要:

Visual Identification: Pale yellow to yellow coloured round shaped film-coated tablets having '5' on one side & symbol like DR. REDDY'S logo on other side of tablet; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Licence status A

承認日:

2014-04-15